Although African Americans are overrepresented among schizophrenia diagnoses, assessments of memory deficits in schizophrenia often do not consider issues of race, ethnicity, and culture. Digit span testing (DST) is often used to assess memory problems associated with schizophrenia. The purpose of the current study was to examine the effects of psychiatric symptoms and demographic background on the DST performances of 128 African American schizophrenic patients. It was hypothesized that level of cultural mistrust would moderate the relationship of psychiatric and demographic variables to memory deficits. The study involved the secondary analysis of data from the Culturally-Sensitive Diagnostic Interview Research Project. Different models of the relationship among predictor variables in their impact on DST performance were tested via structural equation modeling (SEM); and the moderating effects of level of cultural mistrust were evaluated with the best SEM model. The results supported the hypothesis that level of cultural mistrust moderates the relationship among variables in the SEM model. Specifically, psychiatric symptoms negatively impacted DST performance in the low cultural mistrust group, but they had no significant association to the memory deficits of the high cultural mistrust group. The pattern of findings for the effects of psychiatric symptoms on DST performance is consistent with the view of cultural mistrust as an adaptive mechanism in African Americans. One implication is that cultural factors should be taken into account when assessing memory deficits in African Americans with schizophrenia.
Psychiatric Quarterly – Springer Journals
Published: Jul 22, 2011
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud